Prashant Kohli insider trades

Open-market stock purchases and sales by Prashant Kohli, Chief Executive Officer at Grace Therapeutics, Inc, from SEC Form 4 filings since Jul 14, 2023.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -11%.

Recent trades

DateStockTradeValue
Sep 9, 2026GRCE Grace Therapeutics, IncBought$214K
Aug 28, 2026GRCE Grace Therapeutics, IncBought (not open market)—

Companies traded

  • GRCE Grace Therapeutics, Inc: 1 buy, last Sep 9, 2026
  • ACST Acasti Pharma Inc: other filings, last May 6, 2024

Get free alerts when Prashant Kohli files a new trade →